Watchlist Price Alert

Sensus Healthcare Inc. (SRTS)

NASDAQ: SRTS · Real-Time Price · USD

4.72

-0.02 (-0.42%)

At close: Jul 01, 2025, 1:36 PM

-0.42% (1D)

Bid	4.7
Market Cap	77.62M
Revenue (ttm)	39.49M
Net Income (ttm)	1.8M
EPS (ttm)	0.11
PE Ratio (ttm)	42.91
Forward PE	10.08
Analyst	Buy

Ask	4.78
Volume	33,009
Avg. Volume (20D)	91,126
Open	4.74
Previous Close	4.74
Day's Range	4.69 - 4.75
52-Week Range	4.01 - 9.33
Beta	1.32

About SRTS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol SRTS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SRTS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Sensus Healthcare Inc. is scheduled to release its earnings on Aug 7, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 months ago

-32.37%

Sensus Healthcare shares are trading lower after t... Unlock content with Pro Subscription

4 months ago

+6.52%

Sensus Healthcare shares are trading lower after the company reported mixed Q4 financial results.

News

4 days ago · businesswire.com

Sensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists

BOCA RATON, Fla.--(BUSINESS WIRE)---- $SRTS--Sensus Healthcare, Inc. (Nasdaq: SRTS) (Sensus or the Company), a medical device company specializing in highly effective, non-invasive, minimally-invasive...

3 weeks ago · zacks.com

Is It Worth Investing in Sensus Healthcare (SRTS) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe...

1 month ago · seekingalpha.com

Sensus Healthcare, Inc. (SRTS) Q1 2025 Earnings Call Transcript

Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Tirth Patel - Alliance Advisors, IR Joe Sardano - Chairman and CEO Michael Sardano ...

1 month ago · zacks.com

Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates

Sensus Healthcare, Inc. (SRTS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of $0.04. This compares to earnings of $0.14 per share a year ago.

1 month ago · businesswire.com

Sensus Healthcare Reports First Quarter 2025 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)---- $SRTS--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective trea...

1 month ago · zacks.com

Sensus Healthcare, Inc. (SRTS) Stock Falls Amid Market Uptick: What Investors Need to Know

In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.22, marking a -0.47% move from the previous day.

2 months ago · businesswire.com

Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments

BOCA RATON, Fla.--(BUSINESS WIRE)--May is Skin Cancer Awareness Month and Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-inv...

2 months ago · zacks.com

Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q1 Earnings Expected to Decline

Sensus Healthcare (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.